Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes

Krishnadev Pillai, Ahmed Fares, Soha Dargham, Jassim Al Suwaidi, Amin Jayyousi, Charbel Abi Khalil

Open source

DOI
10.3389/fendo.2023.1147225
Published
2023-05-26
Container
Frontiers in Endocrinology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2023.1147225,
  title = {Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes},
  author = {Krishnadev Pillai and Ahmed Fares and Soha Dargham and Jassim Al Suwaidi and Amin Jayyousi and Charbel Abi Khalil},
  year = {2023},
  journal = {Frontiers in Endocrinology},
  doi = {10.3389/fendo.2023.1147225},
  url = {https://doi.org/10.3389/fendo.2023.1147225}
}

RIS

TY  - JOUR
TI  - Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes
AU  - Krishnadev Pillai
AU  - Ahmed Fares
AU  - Soha Dargham
AU  - Jassim Al Suwaidi
AU  - Amin Jayyousi
AU  - Charbel Abi Khalil
PY  - 2023
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2023.1147225
UR  - https://doi.org/10.3389/fendo.2023.1147225
ER  - 

APA

Pillai, K., Fares, A., Dargham, S., Suwaidi, J. A., Jayyousi, A., & Khalil, C. A. (2023). Primary hyperaldosteronism is associated with increased mortality and morbidity in patients with hypertension and diabetes. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1147225

Source records